How it works: inflammation and matrix remodeling
Delivering copper is only half the story.
Tuning inflammation and rebuilding the matrix
Delivering copper is only half the story. The other half is what GHK-Cu does to fibroblasts and to the signals that decide whether a wound resolves or stays stuck in inflammation. In culture it raises fibroblasts’ output of collagen, elastin and sulfated glycosaminoglycans.
This unit covers the cytokine tuning, the matrix-metalloproteinase balance between building and breaking down, and the fibroblast effects that underpin the skin and wound reputation. Most of it is in-vitro and animal work, which we flag throughout.
Key terms
From damage signal to resolution
GHK-Cu is studied less as an off-switch for inflammation and more as a nudge toward resolution, the phase where inflammation winds down and rebuilding begins. A 2008 review frames it around tissue remodeling, which it describes as following the initial phase of wound healing, stopping inflammatory and scar-forming processes, and then restoring normal tissue structure.
This is a very different goal from a steroid or an NSAID, which blunt the initial alarm. The distinction matters because resolution, not suppression, is what lets tissue actually rebuild. As always, this pathway is drawn mainly from cell and animal models.
AdvancedWhat "anti-inflammatory" means here
In these models GHK-Cu shifts the balance of inflammatory mediators rather than shutting inflammation off, closer to accelerating resolution than blocking the response, which is why it is studied for repair rather than as an anti-inflammatory drug.